About AOP Health
AOP Health is a company based in Vienna (Austria) founded in 1996 by Rudolf Widmann. It operates as a B2B. AOP Health operates in a competitive market with competitors including Insulet, Lyra Therapeutics, Editas Medicine, GBT and TriSalus Life Sciences, among others.
- Headquarter Vienna, Austria
- Founders Rudolf Widmann
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website aop-health.com/us_en
- Social LinkedIn YouTube
People of AOP Health
9 people are tracked at AOP Health (5 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Rudolf Widmann | Founder, CEO | Leadership |
Dr. Martin Steinhart | Co-Chief Executive Officer | Leadership |
Maarten Manders | Managing Director/ Country Manager Benelux | Leadership |
Sofia Opitz | Managing Director, VD AOP Nordics | Leadership |
Modestas Jocius | Regional Manager Baltic States, Head Of Representative Office | Leadership |
Katja Salminen | Key Account Manager | Team |
Catharina Lundmark | Sales And Marketing Manager Nordics | Team |
Terrence Janssen | Key Account Manager Benelux | Team |
Kajsa Fridman | Key Account Manager | Team |
Complete people profiles for AOP Health
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of AOP Health
AOP Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insulet, Lyra Therapeutics, Editas Medicine, GBT and TriSalus Life Sciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insulet.com | 2000 | Boston, United States | $120.4M | 2,600 | Wearable insulin infusion systems are developed for diabetes patients. | |
| lyratherapeutics.com | 2005 | Watertown, United States | $127.61M | 75 | Small molecule therapeutics for ENT diseases are developed. | |
| editasmedicine.com | 2013 | Cambridge, United States | $210M | 257 | Therapeutics for rare genetic diseases are developed using CRISPR technology. | |
| gbt.com | 2011 | San Francisco, United States | $177.4M | 457 | Small molecules are developed for sickle cell disease treatment. | |
| trisaluslifesci.com | 2009 | Westminster, United States | $83.37M | 100 | Developer of drug delivery devices to treat cancers | |
| credencemed.com | 2011 | Menlo Park, United States | $112.61M | – | Developer of smart devices for drug delivery | |
| cellectar.com | 2002 | Florham Park, United States | – | 15 | Phospholipid drug conjugates for cancer treatment are developed. | |
| foreseepharma.com | 2011 | Taipei, Taiwan | $32.5M | – | Injectables and NCEs for cancer and chronic diseases are developed. | |
| genprex.com | 2009 | Austin, United States | $3.11M | 28 | Therapeutics for molecular-level cancer treatment are developed. |
Detailed competitors of AOP Health
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AOP Health
The website of AOP Health (aop-health.com) receives about 20.5K visits a month and ranks #1,322,039 among all websites worldwide, #1,707 in Biotechnology and Pharmaceuticals.
- Monthly visits20.5K
▲ 5.2% vs previous month
- Unique visitors8.6K
per month
- Global rank#1,322,039
among all websites
- Category rank#1,707
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit2.0
- Average visit30 sec
- DevicesDesktop 41% · Mobile 59%
Latest news on Aop Health
Complete news archive for AOP Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to AOP Health
10 companies that operate in the same segment as AOP Health (Rare Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Solutions for genetic diseases are developed using CRISPR-Cas9 genome editing. | 2013 | Basel, Basel-stadt, Switzerland | USD 127 M | USD 37.31 M | 393 | |
Gene therapies for rare diseases are developed to treat patients. | 2020 | Columbus, Ohio, United States | USD 250 M | – | – | |
Developing small molecules for control mechanisms and genes regulation for the treatment of rare diseases | 2015 | Cambridge, Massachusetts, United States | USD 114.67 M | – | 45 | |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies | 2010 | Boston, Massachusetts, United States | USD 84 M | USD 189.76 M | 283 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Therapies for gastrointestinal diseases are developed by Phathom Pharmaceuticals. | 2019 | Menlo Park, California, United States | USD 90 M | USD 175.11 M | 427 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AOP Health
AOP Health was founded in 1996.
AOP Health is headquartered in Vienna, Austria.
Rudolf Widmann is the current CEO of AOP Health. They have also founded this company.
AOP Health, based in Vienna, focuses on providing healthcare solutions, advancing biotech innovations, rare diseases, and treatment technologies. Develops innovative technologies for treatments targeting rare diseases. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
AOP Health's top competitors include Insulet, Lyra Therapeutics and GBT.